Trial Condition(s):
Menorrhagia, Contraceptive Devices, Intrauterine
Study to compare efficacy and safety of Levonorgestrel-releasing Intrauterine system to a three-month administration of danazol in women with menorrhagia
Bayer Identifier:
90589
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
151
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Randomized, open-label, multicenter study comparing the efficacy and safety of Mirena to a three-month administration of danazol followed by a 3-month observation period in women aged over 30 with functional menorrhagia
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
